BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 14607868)

  • 1. CD56+-T-cell responses to bacterial superantigens and immune recognition of attenuated vaccines.
    Saikh KU; Dyas B; Kissner T; Ulrich RG
    Clin Diagn Lab Immunol; 2003 Nov; 10(6):1065-73. PubMed ID: 14607868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human natural killer (NK) cells present staphylococcal enterotoxin B (SEB) to T lymphocytes.
    D'Orazio JA; Stein-Streilein J
    Clin Exp Immunol; 1996 May; 104(2):366-73. PubMed ID: 8625534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of human T cells with NK cell markers by staphylococcal enterotoxin A via IL-12 but not via IL-18.
    Ami K; Ohkawa T; Koike Y; Sato K; Habu Y; Iwai T; Seki S; Hiraide H
    Clin Exp Immunol; 2002 Jun; 128(3):453-9. PubMed ID: 12109440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ex vivo expansion of CD8+CD56+ and CD8+CD56- natural killer T cells specific for MUC1 mucin.
    Wajchman HJ; Pierce CW; Varma VA; Issa MM; Petros J; Dombrowski KE
    Cancer Res; 2004 Feb; 64(3):1171-80. PubMed ID: 14871854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MHC class II-dependent peptide antigen versus superantigen presentation to T cells.
    Shoukry NH; Lavoie PM; Thibodeau J; D'Souza S; Sekaly RP
    Hum Immunol; 1997 May; 54(2):194-201. PubMed ID: 9297538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A kinetic comparative study on lymphocyte responses to superantigen and phytohemagglutinin: reciprocal presentation of superantigen on the surface of activated lymphocytes.
    Ijichi S; Yamano Y; Osame M; Hall WW
    Cell Immunol; 1996 Nov; 173(2):312-6. PubMed ID: 8912892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. beta-cell antigen-specific CD56(+) NKT cells from type 1 diabetic patients: autoaggressive effector T cells damage human CD56(+) beta cells by HLA-restricted and non-HLA-restricted pathways.
    Ou D; Metzger DL; Wang X; Pozzilli P; Tingle AJ
    Hum Immunol; 2002 Apr; 63(4):256-70. PubMed ID: 12039407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA class I-specific inhibitory receptors in human T lymphocytes: interleukin 15-induced expression of CD94/NKG2A in superantigen- or alloantigen-activated CD8+ T cells.
    Mingari MC; Ponte M; Bertone S; Schiavetti F; Vitale C; Bellomo R; Moretta A; Moretta L
    Proc Natl Acad Sci U S A; 1998 Feb; 95(3):1172-7. PubMed ID: 9448304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of human T cells by major histocompatability complex class II expressing neutrophils: proliferation in the presence of superantigen, but not tetanus toxoid.
    Fanger NA; Liu C; Guyre PM; Wardwell K; O'Neil J; Guo TL; Christian TP; Mudzinski SP; Gosselin EJ
    Blood; 1997 Jun; 89(11):4128-35. PubMed ID: 9166855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells.
    Eberl G; Lees R; Smiley ST; Taniguchi M; Grusby MJ; MacDonald HR
    J Immunol; 1999 Jun; 162(11):6410-9. PubMed ID: 10352254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD1d-independent activation of mouse and human iNKT cells by bacterial superantigens.
    Hayworth JL; Mazzuca DM; Maleki Vareki S; Welch I; McCormick JK; Haeryfar SM
    Immunol Cell Biol; 2012 Aug; 90(7):699-709. PubMed ID: 22041925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intercellular adhesion molecule-1 and leukocyte function-associated antigen-3 provide costimulation for superantigen-induced T lymphocyte proliferation in the absence of a specific presenting molecule.
    Lamphear JG; Stevens KR; Rich RR
    J Immunol; 1998 Jan; 160(2):615-23. PubMed ID: 9551895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human eosinophils as antigen-presenting cells: relative efficiency for superantigen- and antigen-induced CD4+ T-cell proliferation.
    Mawhorter SD; Kazura JW; Boom WH
    Immunology; 1994 Apr; 81(4):584-91. PubMed ID: 7518797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of T cell lymphokine production by killer cell inhibitory receptor recognition of self HLA class I alleles.
    D'Andrea A; Chang C; Phillips JH; Lanier LL
    J Exp Med; 1996 Aug; 184(2):789-94. PubMed ID: 8760835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Participation of CD1 molecules in the presentation of bacterial protein antigens in humans.
    Ulanova M; Tarkowski A; Hahn-Zoric M; Hanson LA
    Scand J Immunol; 1999 Oct; 50(4):387-93. PubMed ID: 10520178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of immune responses by CD1d-restricted natural killer T cells.
    Van Kaer L
    Immunol Res; 2004; 30(2):139-53. PubMed ID: 15477656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staphylococcal exotoxins deliver activation signals to human T-cell clones via major histocompatibility complex class II molecules.
    Spertini F; Spits H; Geha RS
    Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7533-7. PubMed ID: 1881894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variable influence of MHC polymorphism on the recognition of bacterial superantigens by T cells.
    Wen R; Blackman MA; Woodland DL
    J Immunol; 1995 Aug; 155(4):1884-92. PubMed ID: 7636239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigen Presentation by CD1 Lipids, T Cells, and NKT Cells in Microbial Immunity.
    Cohen NR; Garg S; Brenner MB
    Adv Immunol; 2009; 102():1-94. PubMed ID: 19477319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The dual-functional capability of cytokine-induced killer cells and application in tumor immunology.
    Zhang Q; Liu XY; Zhang T; Zhang XF; Zhao L; Long F; Liu ZK; Wang EH
    Hum Immunol; 2015 May; 76(5):385-91. PubMed ID: 25305457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.